Literature DB >> 8661116

Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity.

Z Wang1, P Sicinski, R A Weinberg, Y Zhang, K Ravid.   

Abstract

The three D-type cyclins have been shown to be differentially expressed in a number of cell types, suggesting that they play distinct roles in cell cycle regulation in particular cell lineages. We have determined the complete nucleotide sequence (-1681 to + 6582) of the mouse cyclin D3 gene, which encodes a G1 phase cyclin. The gene consists of five exons and four introns, varying in length from 422 to 2472 bp. Primer extension analysis revealed one major transcription initiation site at the position 107 bp 5' upstream of the translation start. The promoter region lacks both canonical "TATA" and "CAAT" boxes. It contains, however, multiple transcription factor recognition sites, including multiple "GC-rich" sequences to which Sp1 factor binds and sequences recognized by GATA, NF-kappaB, ATF, E2F, and TRE/AP1 transcription factors, E box binding myogenic factors, and the IL-6 induced-transcription factor, APRF. Promoter activity of the 1681-bp fragment upstream of the transcription initiation site was confirmed by linking it to a reporter gene and subjecting it to transient expression experiments in various cell types. Promoter activity was high in cell lines that expressed high levels of endogenous D3 mRNA, as indicated by Northern blot analyses, and was significantly reduced when the promoter was truncated to -122 bp. The characterization of the mouse cyclin D3 gene and insight into its promoter region will allow further studies defining the molecular events regulating the expression of this cyclin in proliferating and quiescent cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661116     DOI: 10.1006/geno.1996.0334

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

Review 1.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  A role for cyclin D3 in the endomitotic cell cycle.

Authors:  J M Zimmet; D Ladd; C W Jackson; P E Stenberg; K Ravid
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis.

Authors:  Anne Müller; Antje Dickmanns; Claudia Resch; Knut Schäkel; Stephan Hailfinger; Matthias Dobbelstein; Klaus Schulze-Osthoff; Daniela Kramer
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

Authors:  F Depoortere; I Pirson; J Bartek; J E Dumont; P P Roger
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

5.  Cyclin D2 overexpression in transgenic mice induces thymic and epidermal hyperplasia whereas cyclin D3 expression results only in epidermal hyperplasia.

Authors:  M L Rodriguez-Puebla; M LaCava; P L Miliani De Marval; J L Jorcano; E R Richie; C J Conti
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Promotion of cell cycle progression by basic helix-loop-helix E2A.

Authors:  F Zhao; A Vilardi; R J Neely; J K Choi
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

7.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.

Authors:  Noemí Alejandra Saavedra-Ávila; Upasana Sengupta; Begoña Sánchez; Ester Sala; Laura Haba; Thomas Stratmann; Joan Verdaguer; Dídac Mauricio; Belén Mezquita; Ana Belén Ropero; Ángel Nadal; Conchi Mora
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

9.  c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms.

Authors:  R Wisdom; R S Johnson; C Moore
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

10.  Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy.

Authors:  Donald J McCrann; Alexia Eliades; Maria Makitalo; Kuniharu Matsuno; Katya Ravid
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.